COMMUNIQUÉS West-GlobeNewswire
-
Ceapro Inc. Receives Approval from Health Canada to Commence Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
09/10/2018 - 14:00 -
Oryzon announces first patient enrolled in REIMAGINE: a Phase IIa clinical trial with Vafidemstat (ORY-2001) in aggressiveness
09/10/2018 - 14:00 -
Coherus BioSciences Announces New Employment Inducement Grants
09/10/2018 - 14:00 -
OncoMed Announces Upcoming Presentation of Navicixizumab Interim Phase 1b Data at the European Society of Clinical Oncology Meeting
09/10/2018 - 14:00 -
Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board
09/10/2018 - 14:00 -
BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001
09/10/2018 - 14:00 -
OV: Oncology Venture to Participate at Upcoming Investor Events in Q4 2018
09/10/2018 - 13:35 -
Nu-Med Plus, Inc. Announces Strategic Rebrand to Focus on Leading Advancements in the Nitric Oxide Delivery Industry
09/10/2018 - 13:30 -
Wave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases
09/10/2018 - 13:30 -
UPDATE - Aleafia to Launch Industry First 60,000 kg Secure Outdoor Grow Expansion
09/10/2018 - 13:19 -
Myriad and Pfizer Build Upon a Previously Announced Companion Diagnostic Agreement
09/10/2018 - 13:05 -
Resonant Inc. to Introduce New 5G RF Filter Breakthrough at the 2018 IEEE International Ultrasonics Symposium in Kobe, Japan, on October 24th
09/10/2018 - 13:05 -
IMV Inc. to Present at Upcoming Investor Conferences
09/10/2018 - 13:05 -
Ziopharm and Precigen Redefine Relationships, Announce New License Agreement
09/10/2018 - 13:00 -
Radient Technologies Inc. receives Controlled Drugs and Substances Licence for its Manufacturing Facility
09/10/2018 - 13:00 -
Loxo Oncology Announces Details for Data Presentations at the European Society for Medical Oncology 2018 Congress
09/10/2018 - 12:45 -
BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY®
09/10/2018 - 12:30 -
ASLAN Pharmaceuticals to Present Posters on Varlitinib and ASLAN003 at European Society for Medical Oncology Congress
09/10/2018 - 12:15 -
Canopy Rivers Announces Proposed Restructuring of Investment in TerrAscend
09/10/2018 - 12:00
Pages